Open AccessCervical cancer staging, pretreatment planning, and surgical treatment in the Nordic countries—Survey from the Surgical Subcommittee of the Nordic Society of Gynecological Oncology
Author(s) -
Fuglsang Katrine,
Haldorsen Ingfrid S,
AvallLundqvist Elisabeth,
Lindahl Gabriel,
Roed Henrik,
Woie Kathrine,
Pakarinen Päivi,
Thoroddsen Asgeir,
Anttila Maarit,
Blaakær Jan
Publication year - 2018
Publication title -
acta obstetricia et gynecologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.401
H-Index - 102
eISSN - 1600-0412
pISSN - 0001-6349
DOI - 10.1111/aogs.13388
Subject(s) - medicine , cervical cancer , stage (stratigraphy) , gynecologic oncology , magnetic resonance imaging , hysterectomy , positron emission tomography , lymph node , radiology , sentinel lymph node , sentinel node , cancer , breast cancer , surgery , paleontology , biology
Abstract Introduction Women with cervical cancer in the Nordic countries are increasingly undergoing pretreatment imaging by ultrasound, magnetic resonance imaging ( MRI ), positron emission tomography‐computed tomography ( PET ‐ CT ) or computed tomography, or sentinel lymph node procedure. The present survey reports the influence of pretreatment imaging findings on the recorded clinical International Federation of Gynecology and Obstetrics ( FIGO ) stage in Nordic countries and its impact on treatment planning and preferred surgical approach in cervical cancer. Material and methods The Nordic Society of Gynecological Oncology Surgical Subcommittee developed a questionnaire‐based survey that was conducted from 1 January to 31 March 2017. All the 22 Nordic Gynecological Oncology Centers (Denmark 5, Finland 5, Iceland 1, Norway 4, and Sweden 7) were invited to participate. Results The questionnaires were returned by 19 of 22 (86.3%) centers. The median number (range) of women with cervical cancer treated at each center annually was 32 (15‐120). In 58% (11/19) of the centers, imaging findings were reported to influence the clinical staging. MRI in combination with PET ‐ CT was the preferred imaging method and the results influenced treatment planning. Robotic‐assisted radical hysterectomy was the preferred surgical method in 72% (13/18) of the centers. Sentinel lymph node procedure was not routinely implemented in the majority of the Nordic centers. Conclusion More than half of the Nordic Gynecological Oncology Centers already report a clinical FIGO stage influenced by pretreatment imaging findings. The trend in preferred treatment is robotic‐assisted radical hysterectomy and the sentinel lymph node procedure is gradually being introduced.